Cargando…

An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation

Background: Most liver tumors arise on the basis of chronic liver diseases that trigger inflammatory responses. Besides inflammation, subsequent defects in the p53-signaling pathway frequently occurs in liver cancer. In this study, we analyzed the consequences of inflammation and p53 loss in liver c...

Descripción completa

Detalles Bibliográficos
Autores principales: Svinarenko, Michael, Katz, Sarah-Fee, Tharehalli, Umesh, Mulaw, Medhanie A., Maier, Harald J., Sunami, Yoshiaki, Fischer, Sarah K., Chen, Yuexin, Heurich, Sabine, Erkert, Lena, Tannapfel, Andrea, Wirth, Thomas, Schirmbeck, Reinhold, Seufferlein, Thomas, Lechel, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827060/
https://www.ncbi.nlm.nih.gov/pubmed/31546614
http://dx.doi.org/10.3390/cancers11101410
_version_ 1783465238730899456
author Svinarenko, Michael
Katz, Sarah-Fee
Tharehalli, Umesh
Mulaw, Medhanie A.
Maier, Harald J.
Sunami, Yoshiaki
Fischer, Sarah K.
Chen, Yuexin
Heurich, Sabine
Erkert, Lena
Tannapfel, Andrea
Wirth, Thomas
Schirmbeck, Reinhold
Seufferlein, Thomas
Lechel, André
author_facet Svinarenko, Michael
Katz, Sarah-Fee
Tharehalli, Umesh
Mulaw, Medhanie A.
Maier, Harald J.
Sunami, Yoshiaki
Fischer, Sarah K.
Chen, Yuexin
Heurich, Sabine
Erkert, Lena
Tannapfel, Andrea
Wirth, Thomas
Schirmbeck, Reinhold
Seufferlein, Thomas
Lechel, André
author_sort Svinarenko, Michael
collection PubMed
description Background: Most liver tumors arise on the basis of chronic liver diseases that trigger inflammatory responses. Besides inflammation, subsequent defects in the p53-signaling pathway frequently occurs in liver cancer. In this study, we analyzed the consequences of inflammation and p53 loss in liver carcinogenesis. Methods: We used inducible liver-specific transgenic mouse strains to analyze the consequences of NF-κB/p65 activation mimicking chronic inflammation and subsequent p53 loss. Results: Ikk2(ca) driven NF-κB/p65 activation in mice results in liver fibrosis, the formation of ectopic lymphoid structures and carcinogenesis independent of p53 expression. Subsequent deletion of Trp53 led to an increased tumor formation, metastasis and a shift in tumor differentiation towards intrahepatic cholangiocarcinoma. In addition, loss of Trp53 in an inflammatory liver resulted in elevated chromosomal instability and indicated a distinct aberration pattern. Conclusions: In conclusion, activation of NF-κB/p65 mimicking chronic inflammation provokes the formation of liver carcinoma. Collateral disruption of Trp53 supports tumor progression and influences tumor differentiation and heterogeneity.
format Online
Article
Text
id pubmed-6827060
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68270602019-11-18 An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation Svinarenko, Michael Katz, Sarah-Fee Tharehalli, Umesh Mulaw, Medhanie A. Maier, Harald J. Sunami, Yoshiaki Fischer, Sarah K. Chen, Yuexin Heurich, Sabine Erkert, Lena Tannapfel, Andrea Wirth, Thomas Schirmbeck, Reinhold Seufferlein, Thomas Lechel, André Cancers (Basel) Article Background: Most liver tumors arise on the basis of chronic liver diseases that trigger inflammatory responses. Besides inflammation, subsequent defects in the p53-signaling pathway frequently occurs in liver cancer. In this study, we analyzed the consequences of inflammation and p53 loss in liver carcinogenesis. Methods: We used inducible liver-specific transgenic mouse strains to analyze the consequences of NF-κB/p65 activation mimicking chronic inflammation and subsequent p53 loss. Results: Ikk2(ca) driven NF-κB/p65 activation in mice results in liver fibrosis, the formation of ectopic lymphoid structures and carcinogenesis independent of p53 expression. Subsequent deletion of Trp53 led to an increased tumor formation, metastasis and a shift in tumor differentiation towards intrahepatic cholangiocarcinoma. In addition, loss of Trp53 in an inflammatory liver resulted in elevated chromosomal instability and indicated a distinct aberration pattern. Conclusions: In conclusion, activation of NF-κB/p65 mimicking chronic inflammation provokes the formation of liver carcinoma. Collateral disruption of Trp53 supports tumor progression and influences tumor differentiation and heterogeneity. MDPI 2019-09-21 /pmc/articles/PMC6827060/ /pubmed/31546614 http://dx.doi.org/10.3390/cancers11101410 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Svinarenko, Michael
Katz, Sarah-Fee
Tharehalli, Umesh
Mulaw, Medhanie A.
Maier, Harald J.
Sunami, Yoshiaki
Fischer, Sarah K.
Chen, Yuexin
Heurich, Sabine
Erkert, Lena
Tannapfel, Andrea
Wirth, Thomas
Schirmbeck, Reinhold
Seufferlein, Thomas
Lechel, André
An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation
title An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation
title_full An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation
title_fullStr An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation
title_full_unstemmed An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation
title_short An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation
title_sort ikk/nf-κb activation/p53 deletion sequence drives liver carcinogenesis and tumor differentiation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827060/
https://www.ncbi.nlm.nih.gov/pubmed/31546614
http://dx.doi.org/10.3390/cancers11101410
work_keys_str_mv AT svinarenkomichael anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT katzsarahfee anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT tharehalliumesh anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT mulawmedhaniea anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT maierharaldj anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT sunamiyoshiaki anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT fischersarahk anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT chenyuexin anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT heurichsabine anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT erkertlena anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT tannapfelandrea anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT wirththomas anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT schirmbeckreinhold anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT seufferleinthomas anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT lechelandre anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT svinarenkomichael ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT katzsarahfee ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT tharehalliumesh ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT mulawmedhaniea ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT maierharaldj ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT sunamiyoshiaki ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT fischersarahk ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT chenyuexin ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT heurichsabine ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT erkertlena ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT tannapfelandrea ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT wirththomas ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT schirmbeckreinhold ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT seufferleinthomas ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation
AT lechelandre ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation